Literature DB >> 17403482

Lung transplantation in the Fischer 344-->Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans.

M Hirschburger1, S Greschus, T Kuchenbuch, C Plötz, M Obert, H Traupe, W Padberg, V Grau.   

Abstract

BACKGROUND: To elucidate the pathogenesis of bronchiolitis obliterans (BO) a reliable animal model is needed. According to the literature, lung transplantation from Fischer 344 (F344) to Wistar Kyoto (WKY) rats is the only model that reliably results in BO without a further stimulus.
METHODS: We performed orthotopic left lung transplantation in F344 to WKY rats and in both isogeneic rat strain combinations. Suture and cuff techniques for anastomosis were compared. The time course of rejection and the morphology of the bronchial anastomoses were documented by repeated flat-panel volumetric computed tomography (fpVCT) in the living animal. Graft histopathology was analyzed 3 months post-transplant.
RESULTS: According to the graft outcome, as revealed by fpVCT, grafts were sub-divided into two groups: In Group 1, infiltrates due to acute rejection occurred early after transplantation and resolved thereafter. Graft histopathology showed minor changes but no BO. In Group 2, acute rejection caused total atelectasis that never resolved. After 3 months, grafts were shrunken and exhibited tissue remodeling with some similarities to BO. No correlation between graft outcome and anastomotic technique was apparent.
CONCLUSIONS: Modeling lung transplantation using the F344-to-WKY combination is without clinical relevance because BO does not develop in grafts with life-sustaining function. Consecutive fpVCT is useful to monitor pathologic changes in rat pulmonary grafts.

Entities:  

Mesh:

Year:  2007        PMID: 17403482     DOI: 10.1016/j.healun.2007.01.018

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Authors:  Jason M Gauthier; Daniel Ruiz-Pérez; Wenjun Li; Ramsey R Hachem; Varun Puri; Andrew E Gelman; Daniel Kreisel
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

2.  Treatment with keratinocyte growth factor does not improve lung allograft survival in the rat.

Authors:  Markus Hirschburger; Martin Obert; Horst Traupe; Tim Kuchenbuch; Winfried Padberg; Heinz Fehrenbach; Veronika Grau
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

3.  Ferret lung transplant: an orthotopic model of obliterative bronchiolitis.

Authors:  H Sui; A K Olivier; J A Klesney-Tait; L Brooks; S R Tyler; X Sun; A Skopec; J Kline; P G Sanchez; D K Meyerholz; N Zavazava; M Iannettoni; J F Engelhardt; K R Parekh
Journal:  Am J Transplant       Date:  2012-12-03       Impact factor: 8.086

4.  Rattus model utilizing selective pulmonary ischemia induces bronchiolitis obliterans organizing pneumonia.

Authors:  John C Densmore; Paul M Jeziorczak; Anne V Clough; Kirkwood A Pritchard; Breana Cummens; Meetha Medhora; Arjun Rao; Elizabeth R Jacobs
Journal:  Shock       Date:  2013-03       Impact factor: 3.454

5.  LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.

Authors:  Zheng-Liang Tu; Zhen-Yu Zhou; Hai-Chao Xu; Jin-Lin Cao; Peng Ye; Lu-Ming Wang; Wang Lv; Jian Hu
Journal:  J Cardiothorac Surg       Date:  2017-05-25       Impact factor: 1.637

Review 6.  A Comprehensive Review on the Surgical Aspect of Lung Transplant Models in Mice and Rats.

Authors:  Xin Jin; Janne Kaes; Jan Van Slambrouck; Ilhan Inci; Stephan Arni; Vincent Geudens; Tobias Heigl; Yanina Jansen; Marianne S Carlon; Robin Vos; Dirk Van Raemdonck; Yi Zhang; Bart M Vanaudenaerde; Laurens J Ceulemans
Journal:  Cells       Date:  2022-01-30       Impact factor: 6.600

Review 7.  Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?

Authors:  Masaaki Sato
Journal:  Ann Transl Med       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.